The offering is a direct placement to insiders at a modest discount, signaling insider support but also confirming the company's urgent need for capital given its going-concern status. Monitor for further shelf takedowns and the Q3 2026 earnings report for revenue growth trajectory and cash burn rate.
Price Chart
Executive Summary
CapsoVision is conducting a direct registered offering of 3,163,444 shares at $5.69 per share (a ~5% discount to the $5.99 closing price on September 16, 2026) to existing significant stockholders, raising approximately $18.0 million in gross proceeds ($17.8 million net). This takedown from the $250M shelf (filed Aug 13, 2026) adds ~6.3% dilution to the 50.0M shares outstanding, and the company's auditor included a going-concern paragraph in its most recent annual report, underscoring the urgency of this capital raise for R&D, sales, and working capital.
Key Facts
- Offering of 3,163,444 shares at $5.69/share, a ~5% discount to the $5.99 last sale price on Sept 16, 2026
- Gross proceeds ~$18.0M; net proceeds ~$17.8M after ~$165,500 in expenses
- Shares offered directly to existing stockholders, including Star One Global Capital ($5.0M) and Eliyahou Harari ($10.0M), both >5% beneficial owners
- Post-offering shares outstanding: 53,195,592, representing ~6.3% dilution from 50,032,148 shares outstanding as of June 30, 2026
- Net tangible book value per share increases from $0.26 to $0.58; new investors experience immediate dilution of $5.11 per share
- Company had net tangible book value of $13.2M as of June 30, 2026, and auditor included a going-concern explanatory paragraph in the most recent annual report
- Proceeds to be used for general corporate purposes including sales/marketing, R&D, G&A, and working capital
Financial Impact
Dilution of ~6.3% of shares outstanding; immediate per-share dilution of $5.11 for new investors; net proceeds of $17.8M added to a $13.2M net tangible book value base
Risk Factors
- Going-concern risk: auditor included a going-concern explanatory paragraph in the most recent annual report
- Further dilution risk: $232M remaining on the shelf registration, plus outstanding options/warrants for ~3.9M additional shares
- Concentration risk: two >5% stockholders are increasing their stakes, potentially influencing corporate governance
- No underwriter or placement agent — offering was direct, which may indicate limited institutional demand at market price
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001628280-26-062680 |
| Document: 0001628280-26-062680-index-headers.html | 0001628280-26-062680 |
| Document: 0001628280-26-062680-index.html | 0001628280-26-062680 |
| Document: 0001628280-26-062680.txt | 0001628280-26-062680 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | 8-K | $6.92 | awaiting T+60 | — | $6.89 (−0.43%) |
Sep 28, 2026 28d ago | Press Release | $6.92 | awaiting T+60 | — | $6.89 (−0.43%) |
Sep 23, 2026 4w ago | Insider Cluster | $6.17 | awaiting T+60 | — | $6.89 (+11.67%) |
Sep 22, 2026 4w ago | Institutional Cluster | $6.30 | awaiting T+60 | — | $6.89 (+9.37%) |
Sep 18, 2026 5w ago | 424B5 | $6.70 | awaiting T+60 | — | $6.89 (−2.84%) |
Aug 24, 2026 9w ago | EFFECT | $5.83 | awaiting T+60 | — | $6.89 (−18.18%) |
Aug 13, 2026 10w ago | S-3 | $6.46 | awaiting T+60 | — | $6.89 (−6.66%) |
Jul 21, 2026 13w ago | Insider Buy | $6.91 $6.45 | ▼ −6.66% | ▼ −9.92% | $6.89 (−0.29%) |
Jul 10, 2026 15w ago | Insider Buy | $6.22 $6.50 | ▲ +4.50% | ▲ +0.51% | $6.89 (+10.77%) |
Jul 7, 2026 15w ago | Insider Buy | $6.13 $6.32 | ▲ +3.18% | ▲ +0.69% | $6.89 (+12.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers